BSG and gastric cancer: The results showed that RSG exhibited stronger tumor suppressor activities than BSG in in vitro, and in the zebrafish model, the inhibition rate on gastric cancer cell SGC-7901, lung cancer cell A549, and B lymphocyte cell line Ramos of RSG was 78%, 31%, and 83%, respectively [39]. RSG also showed greater inhibition of three types of human gastric cancer cell lines (MKN28, AGS, NCI‐N87) than BSG [40].